- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 24 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 6 residues within 4Å:- Chain A: R.142, I.144, T.148, R.173
- Chain B: N.174
- Chain D: R.142
Ligand excluded by PLIPGOL.3: 3 residues within 4Å:- Chain A: W.399, E.403, R.407
Ligand excluded by PLIPGOL.4: 8 residues within 4Å:- Chain A: D.252, S.253, Q.254, G.255, G.303, Q.304, R.305
- Ligands: NDP.1
Ligand excluded by PLIPGOL.5: 8 residues within 4Å:- Chain A: G.153, D.154, V.157, G.159, G.182, R.193, N.231
- Ligands: NDP.1
Ligand excluded by PLIPGOL.6: 5 residues within 4Å:- Chain A: Q.12, N.323, T.350, Q.351, A.352
Ligand excluded by PLIPGOL.9: 3 residues within 4Å:- Chain B: W.399, E.403, R.407
Ligand excluded by PLIPGOL.12: 3 residues within 4Å:- Chain C: W.399, E.403, R.407
Ligand excluded by PLIPGOL.13: 8 residues within 4Å:- Chain C: D.252, S.253, Q.254, G.255, G.303, Q.304, R.305
- Ligands: NDP.11
Ligand excluded by PLIPGOL.14: 7 residues within 4Å:- Chain C: R.142
- Chain E: R.142, I.144, T.148, R.173
- Chain F: N.174
- Ligands: GOL.15
Ligand excluded by PLIPGOL.15: 5 residues within 4Å:- Chain C: R.142, H.143
- Chain E: R.142, H.143
- Ligands: GOL.14
Ligand excluded by PLIPGOL.16: 8 residues within 4Å:- Chain A: R.396
- Chain B: D.147
- Chain C: A.146, E.177, G.178, N.393, S.394, R.396
Ligand excluded by PLIPGOL.17: 3 residues within 4Å:- Chain C: E.242, L.243, G.244
Ligand excluded by PLIPGOL.20: 6 residues within 4Å:- Chain A: R.142
- Chain D: R.142, I.144, T.148, R.173
- Chain E: N.174
Ligand excluded by PLIPGOL.21: 3 residues within 4Å:- Chain D: W.399, E.403, R.407
Ligand excluded by PLIPGOL.22: 8 residues within 4Å:- Chain D: D.252, S.253, Q.254, G.255, G.303, Q.304, R.305
- Ligands: NDP.19
Ligand excluded by PLIPGOL.23: 8 residues within 4Å:- Chain D: G.153, D.154, V.157, G.159, G.182, R.193, N.231
- Ligands: NDP.19
Ligand excluded by PLIPGOL.24: 5 residues within 4Å:- Chain D: Q.12, N.323, T.350, Q.351, A.352
Ligand excluded by PLIPGOL.27: 3 residues within 4Å:- Chain E: W.399, E.403, R.407
Ligand excluded by PLIPGOL.30: 3 residues within 4Å:- Chain F: W.399, E.403, R.407
Ligand excluded by PLIPGOL.31: 8 residues within 4Å:- Chain F: D.252, S.253, Q.254, G.255, G.303, Q.304, R.305
- Ligands: NDP.29
Ligand excluded by PLIPGOL.32: 7 residues within 4Å:- Chain B: R.142, I.144, T.148, R.173
- Chain C: N.174
- Chain F: R.142
- Ligands: GOL.33
Ligand excluded by PLIPGOL.33: 5 residues within 4Å:- Chain B: R.142, H.143
- Chain F: R.142, H.143
- Ligands: GOL.32
Ligand excluded by PLIPGOL.34: 8 residues within 4Å:- Chain D: R.396
- Chain E: D.147
- Chain F: A.146, E.177, G.178, N.393, S.394, R.396
Ligand excluded by PLIPGOL.35: 3 residues within 4Å:- Chain F: E.242, L.243, G.244
Ligand excluded by PLIP- 6 x TLA: L(+)-TARTARIC ACID(Non-covalent)
TLA.7: 15 residues within 4Å:- Chain A: K.78, G.79, G.80, Q.99, K.102, K.114, A.152, G.153, D.154, T.181, R.193, N.346, V.383, S.386
- Ligands: NDP.1
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:G.80, A:Q.99, A:G.153, A:D.154, A:T.181, A:R.193, A:N.346, A:S.386
- Salt bridges: A:K.78, A:K.102, A:K.114, A:R.193
TLA.10: 15 residues within 4Å:- Chain B: K.78, G.79, G.80, Q.99, K.102, K.114, A.152, G.153, D.154, T.181, R.193, N.346, V.383, S.386
- Ligands: NDP.8
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:G.80, B:Q.99, B:K.114, B:D.154, B:R.193, B:N.346, B:V.383, B:S.386
- Salt bridges: B:K.78, B:K.102, B:K.114, B:R.193
TLA.18: 15 residues within 4Å:- Chain C: K.78, G.79, G.80, Q.99, K.102, K.114, A.152, G.153, D.154, R.193, N.346, G.382, V.383, S.386
- Ligands: NDP.11
10 PLIP interactions:10 interactions with chain C- Hydrogen bonds: C:G.80, C:Q.99, C:Q.99, C:N.346, C:G.382, C:S.386
- Salt bridges: C:K.78, C:K.102, C:K.114, C:R.193
TLA.25: 15 residues within 4Å:- Chain D: K.78, G.79, G.80, Q.99, K.102, K.114, A.152, G.153, D.154, T.181, R.193, N.346, V.383, S.386
- Ligands: NDP.19
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:G.80, D:Q.99, D:G.153, D:D.154, D:T.181, D:R.193, D:N.346, D:S.386
- Salt bridges: D:K.78, D:K.102, D:K.114, D:R.193
TLA.28: 15 residues within 4Å:- Chain E: K.78, G.79, G.80, Q.99, K.102, K.114, A.152, G.153, D.154, T.181, R.193, N.346, V.383, S.386
- Ligands: NDP.26
12 PLIP interactions:12 interactions with chain E- Hydrogen bonds: E:G.80, E:Q.99, E:K.114, E:D.154, E:R.193, E:N.346, E:V.383, E:S.386
- Salt bridges: E:K.78, E:K.102, E:K.114, E:R.193
TLA.36: 15 residues within 4Å:- Chain F: K.78, G.79, G.80, Q.99, K.102, K.114, A.152, G.153, D.154, R.193, N.346, G.382, V.383, S.386
- Ligands: NDP.29
10 PLIP interactions:10 interactions with chain F- Hydrogen bonds: F:G.80, F:Q.99, F:Q.99, F:N.346, F:G.382, F:S.386
- Salt bridges: F:K.78, F:K.102, F:K.114, F:R.193
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Godsora, B.K.J. et al., Molecular insights into the inhibition of glutamate dehydrogenase by the dicarboxylic acid metabolites. Proteins (2022)
- Release Date
- 2021-12-08
- Peptides
- Glutamate dehydrogenase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
AE
BF
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 24 x GOL: GLYCEROL(Non-functional Binders)
- 6 x TLA: L(+)-TARTARIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Godsora, B.K.J. et al., Molecular insights into the inhibition of glutamate dehydrogenase by the dicarboxylic acid metabolites. Proteins (2022)
- Release Date
- 2021-12-08
- Peptides
- Glutamate dehydrogenase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
AE
BF
C